Our Team.

Our research is dedicated to pushing the boundaries of current analytical methodologies by developing cutting-edge techniques that enhance the resolution and sensitivity of glycomics and glycoproteomic analysis, particular at the single-cell level. By leveraging state-of-the-art instrumentation and innovative analytical approaches, we aim to unravel the complexities of glycosylation patterns in various cellular contexts. This commitment to innovation not only expands our understanding of glycomic variations in healthy versus malignant cells but also positions us at the forefront of cancer research, providing insights that could lead to novel therapeutic strategies. Through interdisciplinary collaboration and a relentless pursuit of knowledge, we strive to transform how glycomics data is interpreted, ultimately contributing to the advancement of personalized medicine.